key: cord-0052302-zsqzjpqi
authors: Matilla-Cuenca, Leticia; Gil, Carmen; Cuesta, Sergio; Rapún-Araiz, Beatriz; Žiemytė, Miglė; Mira, Alex; Lasa, Iñigo; Valle, Jaione
title: Antibiofilm activity of flavonoids on staphylococcal biofilms through targeting BAP amyloids
date: 2020-11-03
journal: Sci Rep
DOI: 10.1038/s41598-020-75929-2
sha: 2a9ddb5f08b301f34629e799f517654288944a72
doc_id: 52302
cord_uid: zsqzjpqi

The opportunistic pathogen Staphylococcus aureus is responsible for causing infections related to indwelling medical devices, where this pathogen is able to attach and form biofilms. The intrinsic properties given by the self-produced extracellular biofilm matrix confer high resistance to antibiotics, triggering infections difficult to treat. Therefore, novel antibiofilm strategies targeting matrix components are urgently needed. The Biofilm Associated Protein, Bap, expressed by staphylococcal species adopts functional amyloid-like structures as scaffolds of the biofilm matrix. In this work we have focused on identifying agents targeting Bap-related amyloid-like aggregates as a strategy to combat S. aureus biofilm-related infections. We identified that the flavonoids, quercetin, myricetin and scutellarein specifically inhibited Bap-mediated biofilm formation of S. aureus and other staphylococcal species. By using in vitro aggregation assays and the cell-based methodology for generation of amyloid aggregates based on the Curli-Dependent Amyloid Generator system (C-DAG), we demonstrated that these polyphenols prevented the assembly of Bap-related amyloid-like structures. Finally, using an in vivo catheter infection model, we showed that quercetin and myricetin significantly reduced catheter colonization by S. aureus. These results support the use of polyphenols as anti-amyloids molecules that can be used to treat biofilm-related infections.

Staphylococcus aureus is one of the leading bacteria causing biofilm-associated infections related with medical devices 1 . The difficulty of treating such infections is aggravated by the intrinsic resistance to antibiotics given by the biofilm structures produced by these bacteria [2] [3] [4] . Therefore, to fight against biofilm-associated infections, investigations have focused on antibiofilm agents targeting the matrix components, so bacteria lose the protection of the matrix, thereby increasing the effectiveness of traditional antibiotic therapies [5] [6] [7] [8] .

Staphylococcus aureus produces a biofilm matrix composed of exopolysaccharides, surface proteins, extracellular DNA and functional amyloids [9] [10] [11] [12] [13] [14] . Two types of amyloids have been described as scaffold biofilm matrix of S. aureus. The first group consists of small peptides known as phenol-soluble modulins (PSMs) 13 . These peptides show a tendency to aggregate in amyloid fibers that contribute to the stabilization and maturation of the biofilm structure by preventing disassembly of the biofilm matrix. The second type of staphylococcal amyloids is the group of facultative amyloids. This group comprises surface-associated proteins that adopt an amyloid-like conformation under specific environmental conditions, as the Biofilm Associated Protein (Bap) present in some strains of S. aureus and in other coagulase negative staphylococci [15] [16] [17] .

Bap is a multidomain secreted protein identified in a transposon-based mutagenesis for the screening of biofilm defective mutants in the bovine mastitis isolate S. aureus V329 18 . Bap promotes biofilm formation through a mechanism that is independent of the biofilm associated polysaccharide PNAG. The bap gene is frequently identified in mastitis-derived staphylococcal species and all the isolates expressing Bap are strong biofilm formers 19 .

Bap undergoes partial proteolytic cleavage, which releases fragments containing the N-terminal region 17 . This region has a molten globule-like conformation that, when the pH becomes acidic, switches to a β-sheet-rich structure and forms amyloid-like fibers 17 . Others Bap homologs behave the same way. The cleavage of N-terminal domain is enough for the formation of amyloid fibers 17, 20 . However, in S. epidermidis, the C-repeat domain contains amyloid peptides that are sufficient for spontaneous formation of amyloid fibers 21 . This makes Bap an excellent target for anti-amyloid compounds to reduce staphylococcal biofilm formation.

Screening for polyphenols with antibiofilm activity against amyloid-mediated biofilm. We choose a collection of polyphenolic compounds, including flavonoids, stilbenoids and phenolic acids, that have been shown to inhibit fibrillization of human and bacterial amyloids with the aim of identifying polyphenols targeting Bap amyloid-like aggregates (Table 1 and Fig. S1 ) 27, 34 . First, we determined the minimum inhibitory concentrations (MIC) of selected polyphenols against S. aureus V329 using the standard broth microdilution method (Table 1) . MIC against S. aureus V329 were 375 μg/ml for curcumin, 500 μg/ml for quercetin, scutellarein and genistein, 750 μg/ml for eriodictyol, 1000 μg/ml for myricetin, baicalein and resveratrol and 2500 μg/ ml for gallic acid. Next, we tested the antibiofilm effect of the polyphenols on S. aureus V329 biofilm administered at sub-MIC dosages. As expected none of the polyphenols at the concentrations tested affected bacterial viability (Fig. S2) . In order to identify polyphenols that specifically inhibit Bap-dependent biofilm formation, we included the S. aureus 15981 strain (bap negative), which formed a polysaccharide (PNAG)-dependent biofilm, as a control. After cultivation of S. aureus V329 and 15981 strains in the presence of 1/50x MIC, 1/100x MIC and 1/500x MIC of the polyphenols, biofilms were stained with crystal violet. Results showed that myricetin (MC), baicalein (BC), and scutellarein (SC) strongly inhibited biofilm formation of S. aureus V329 at 1/50x MIC (MC 20 μg/ ml, BC 20 μg/ml and SC 10 μg/ml) with a percentage of biofilm inhibition of 94% ± 1%, 91% ± 3%, 92% ± 3%, respectively and 1/100x MIC (MC 10 μg/ml, BC 10 μg/ml and SC 5 μg/ml) with a percentage of biofilm reduction of 92% ± 4%, 69% ± 21%, 84% ± 1%, respectively (***P < 0.001, **P < 0.01, *P < 0.05) (Fig. 1A,B) . Quercetin (QC) significantly reduced biofilm at 1/50x MIC (10 μg/ml) with a percentage of biofilm inhibition of 75 ± 2 (**P < 0.01). Only genistein (GN) (10 μg/ml) and baicalein (BC) (20 μg/ml) significantly reduced biofilm of S. aureus 15981 (**P < 0.01, *P < 0.05) (Fig. 1A,B) . With these results, we have established that the minimal biofilm inhibitory concentrations (MBIC) of polyphenols to inhibit biofilms in which Bap is a matrix component are 10 μg/ml for QC, 10 μg/ml for MC and 5 μg/ml for SC, respectively.

To confirm that QC, MC and SC inhibited Bap-dependent biofilm formation we analyzed the antibiofilm activity of the polyphenols against 3 non-related S. aureus strains that express Bap (Newman-Bap, C104 and V858). Quantification of the biofilm formed by these strains after incubation with polyphenols showed a significant reduction of the bacteria adhered to the microtiter plate ( Fig. 2 ) (***P < 0.001). We next analyzed the effect of the polyphenols against the biofilm formed by Bap-producing coagulase negative staphylococcal species S. hyicus, S. saprophyticus and S. simiae. The results showed that QC, MC and SC reduced biofilm formed by the staphylococcal species, even though their effect was not as strong as the effect observed on the S. aureus www.nature.com/scientificreports/ www.nature.com/scientificreports/ strains (*P < 0.05;**P < 0.01;***P < 0.001) (Fig. 2) . Taken together, these results indicated that the QC, MC and SC polyphenols prevent biofilm formation in Bap-producing staphylococcal strains.

Real-time analysis of the antibiofilm effect of the polyphenols on S. aureus. We used the xCEL-Ligence impedance system to quantitatively evaluate the antibiofilm effect of the polyphenols on the S. aureus strains V329 and 15981 on real-time. When the polyphenols QC, MC, BC and SC were added into the culture medium at the MBIC (10 μg/ml for QC, MC, BC, and 5 μg/ml for SC, respectively), a significant reduction in the biofilm mass of S. aureus V329 was observed. Specifically, QC, MC, BC and SC inhibited S. aureus V329 biofilm formation by 37% ± 0.25%, 39% ± 0.09%, 58% ± 0.19% and 50% ± 0.23%, respectively (Fig. 3A ). Interestingly, inhibition of the biofilm formation capacity persisted after 48 h of growth, with significant reductions in the Cell Index (CI), a measure of total biofilm mass, of 33% ± 0.22% for QC, 39% ± 0.25% for MC, 58% ± 0.1% for BC and 58% ± 0.08% for SC (*P < 0.05) (Fig. 3A ). In the case of S. aureus 15981, the addition of QC, MC and SC resulted in a biofilm growth delay that did not cause a significant reduction in the CI values after 48 h of growth ( Fig. 3B ). Only BC inhibited biofilm formation of 15981 by approximately 27% ± 0.37% and 18% ± 0.42% at 24 h and 48 h of biofilm growth respectively (Fig. 3B) . Altogether, these results confirm that the polyphenols QC, MC and SC have a strong and specific capacity to inhibit Bap mediated biofilms, while BC is capable to prevent both the proteinaceous and polysaccharidic biofilm formation process.

Effect of polyphenols on Bap expression. We next evaluated whether the expression of the bap gene was affected by the presence of the polyphenols. We constructed a S. aureus V329-P bap strain, harboring a transcriptional fusion between bap promoter and gfpmut2 expressed in plasmid pCN52. Western blot using anti-GFP specific antibodies revealed that the addition of MBIC of QC, MC and SC did not affect bap promoter expression (Fig. 4A) . Alternatively, polyphenols could inhibit biofilm development by reducing the amount of Bap anchored to the bacterial surface. Thus, we analyzed the levels of the Bap protein of the cell surface fraction of S. aureus V329 grown until exponential phase in the presence of MBICs of the polyphenols. Western immunoblotting using anti-Bap antibodies showed the same levels of Bap in all the samples (Fig. 4B ). Since polyphenols did not affect Bap expression, we hypothesized that they might inhibit biofilm formation by physically interfering with the capacity of Bap to form amyloid aggregates. To evaluate this hypothesis, we monitored Bap aggregation using native gel electrophoresis of S. aureus V329 cells in the presence of QC, MC and SC, grown until late stationary phase which is the growth stage where the Bap amyloid-like aggregates are formed 17 . Western immunoblotting showed the presence of several bands of high molecular weight (~ 1000 kDa) corresponding to Bap aggregates in the absence of polyphenols. The amount of aggregates was lower when bacteria were cultured in the presence of the polyphenols (Fig. 4C) . These data suggest that polyphenols affected the formation of Bap amyloid-like aggregates.

Antibiofilm activity of polyphenols against 3 non-related S. aureus strains that express Bap (C104, V858 and Newman-Bap) and other staphylococcal species (S. hycus, S. simiae and S. saprophytycus) that form Bap-dependent biofilms. MBIC were used as 10 μg/ml for quercetin (QC), 10 μg/ml for myricetin (MC) and 5 μg/ml for scutellarein (SC). 2% of DMSO was added as control (Ø). Bacteria cultured in TSB-glu media were used as positive control (−). Crystal violet was quantified by measuring absorbance at 595 nm. Statistical significance was determined with one-way ANOVA followed by multiple comparison test (*P < 0.05;**P < 0.01; ***P < 0.001).

| (2020) 10:18968 | https://doi.org/10.1038/s41598-020-75929-2 www.nature.com/scientificreports/ Fig. S3 ). Similar results were obtained when polyphenols were added to E. coli cells expressing Bap_B domain of S. saprophyticus (Fig. 5B) . Furthermore, electron microscopy analysis of the E. coli strain exporting the S. aureus Bap_B domain revealed the presence of extracellular fibrous aggregates surrounding the cells. However, fibrillar structures were not observed in E. coli strain cultured in the presence of polyphenols (Fig. 5C ). These results confirmed that polyphenols inhibit bacterial amyloid formation.

The polyphenols hinder the formation of rBap_B amyloid polymerization. To investigate whether the polyphenols modulate Bap amyloid aggregation independently of additional bacterial factors, we measured the capacity of a purified recombinant protein comprising exclusively the B region of Bap (rBap_B) to bind Th-T in the presence of polyphenols. The results showed that rBap_B polymerization was significantly inhibited in the presence of polyphenols (Fig. 6A) . None of the polyphenolic molecules displayed background fluorescence in these conditions when they were assayed without the rBap_B protein (Fig. 6B ).

To confirm that the polyphenols identified were true aggregation inhibitors and not a misleading artefact produced by the displacement of Th-T from amyloid by polyphenols, we used a turbidimetric assay 36 . Aggregation of rBap_B gives rise to high molecular weight aggregates that scatter light and increase the turbidity of the solution. Recombinant rBap_B was incubated in the presence of each polyphenolic compound QC, MC and SC www.nature.com/scientificreports/ for 3 h, and the absorbance at 360 nm was measured over time. The three polyphenols reduced the building of turbidity in the rBap_B solution and were considered to be aggregation inhibitors (Fig. 6C ).

important for the colonization and persistence of indwelling medical devices by S. aureus in vivo 17 . Therefore, we decided to investigate whether the polyphenols were able to reduce S. aureus colonization of implanted subcutaneous catheters in vivo. For this purpose, polyphenols were administered subcutaneously after catheter implantation and repeated daily. At day 10, all animals were killed and catheters were extracted for colonyforming unit (CFU) counting. The results showed that treatment with QC and MC significantly reduced the number of bacteria attached to the catheter with percentage reduction of 53% ± 13% and 54% ± 17%, respectively (**P < 0.01;***P < 0.001) (Fig. 7) . Treatment with SC, slightly reduced the catheter colonization by S. aureus, but the reduction was not statistically significant.

Several therapeutic alternatives have been proposed to treat medical device-related infections. These include the use of effective antibiofilm molecules or substances that dissolve the biofilm matrix 9 . Here, we show that the polyphenols quercetin (QC), myricetin (MC) and scutellarein (SC) efficiently inhibit the staphylococcal biofilm matrix by specifically targeting Bap-like amyloids. Particularly, MC and its derivative QC acts as molecules that reduces S. aureus Bap-mediated biofilms using an in vivo catheter infection mice model. Polyphenols are a group of biologically active secondary metabolites of plants able to disturb the polymerization of human amyloids responsible for important disorders by inhibiting toxic amyloid formation and/ www.nature.com/scientificreports/ or remodeling or degrading amyloid oligomers and fibrils 26, 27 . The structure similarities between human and bacterial amyloids have led to think that polyphenols may affect amyloid-based biofilms. One example is the polyphenol epigallocatechin-3-gallate (EGCG) that has been shown to inhibit the oligomerization of multiple human amyloids such as amyloid-β 37-39 , α-synuclein 38,40-42 , islet amyloid polypeptide 43, 44 , huntingtin 45 , tau protein 46 and prion proteins 47 , but it is also considered an effective agent for remodeling of bacterial amyloid fibrils as FapC in Pseudomonas sp. strains 48 , the amyloid proteins P1, WapA and Smu_63c of Streptococcus mutans 49 , CsgA in Enterobacteria 50,51 . In staphylococcal species EGCG prevents phenol-soluble modulins (PSM) fibril formation and hinders Bap mediated biofilms 17, 52, 53 . These findings support the hypothesis that polyphenols that are capable to inhibit human amyloids can be used to prevent staphylococcal biofilm formation by avoiding Bap protein to form functional amyloid-like fibers.

Our results showed that QC, MC and SC inhibit S. aureus biofilm formation by targeting Bap amyloids without affecting Bap expression. Although the exact mechanism by which these polyphenols reduce Bap aggregation remains unknown it is likely that a direct interaction of polyphenols with different forms of the oligomers could impede the polymerization of the fibers. Our Th-T assay confirms that rBap_B aggregation kinetics follows a sigmoidal curve with a small lag phase that reflects a rapid nucleation-dependent growth and flavonoids disrupt this mechanism. These evidences demonstrate that QC, MC and SC likely bind monomeric Bap_B or early oligomers preventing its oligomerization into amyloid fibrils and thus, inhibiting S. aureus biofilm formation.

It is likely that the reason for the inhibitory process of Bap mediated biofilms between the different polyphenols is related to the polyphenolic structure. The aromatic rings of polyphenols may interact and compete with the prevalent aromatic residues (Phe and Trp) of the amyloids and block the self-assembly process and the fiber formation. Furthermore, the hydrophobic hydroxyl groups of polyphenols could bind to the hydrophobic residues of amyloid proteins and inhibit amyloidogenesis 54 . Thus, the selected flavonoids have 3 phenolic rings, at least 3 hydroxyl groups and in all cases 2 of them are vicinal, which are reported to have higher inhibitory effects on human amyloid proteins 34 . Interestingly, QC and MC are closely related in structure, with only one hydroxyl group of difference. The same occurs between SC and BC (Fig. S1 ). This may explain why these four polyphenols had the strongest inhibitory effect against S. aureus V329 biofilm. It is noteworthy that BC is able to inhibit both amyloid-like and PNAG-dependent biofilms. On the one hand, BC showed a significant reduction of an amyloid-like biofilm at sub-MIC concentrations of 20 μg/ml and 10 μg/ml ( 1/50x MIC and 1/100x MIC). On the other hand, it also reduced PNAG-dependent biofilm of S. aureus 15981 at a concentration of 20 μg/ml. Although we discarded this polyphenol from this study due to its broad action, the inhibitory effect of BC on the two types of biofilms make it a promising candidate polyphenol and it would be worth undertaking more detailed studies in the future.

The effect of QC, MC and SC on Bap amyloid assembly was analyzed using the C-DAG system, which provides several advantages: (i) it enables the study of molecule modulators of amyloid aggregation under a uniform set of conditions, (ii) it allows to screen the effect of anti-amyloid molecules directly against the amyloid domain of a protein (Bap_B domain), (iii) it allows independence from the genetic background of S. aureus since Bap protein is heterologous expressed in an E. coli strain. We also used the C-DAG system to expand the anti-amyloid effect of the polyphenols to the amyloid domains of Bap homologs from staphylococcal coagulase negative. Therefore, this methodology could be used to extend the possible antibiofilm effect of polyphenols on other proteins of the BAP family or other amyloid proteins.

Microbial amyloids are potential contributors to the infectious process 15, [55] [56] [57] . In the present study we have shown that QC and MC, which are closely related in structure, effectively reduced S. aureus colonization in vivo www.nature.com/scientificreports/ in a murine subcutaneous catheter infection model. The administration of these molecules may allow to minimize not only the effective doses of each agent but also fight the emergence of drug-resistant bacteria. Bap of S. aureus belongs to the Biofilm Associated Protein (BAP) family. Homologous Bap proteins are present in many pathogenic bacteria. Our previous results suggest that the mechanism of amyloid-like aggregation might be widespread among these proteins 17, 20 . This assumption opens an exciting line of research to consider BAP proteins as molecular targets of polyphenols to fight against biofilm related infections.

Bacterial strains and growth conditions. S. aureus V329 and 15981 were used as model strains. S. aureus V329 isolated from a bovine mastitis expresses Bap and forms amyloid-like biofilms. Deletion of bap gene abolishes biofilm formation in this strain 18 . S. aureus 15981 is a bap negative clinical isolate that forms polysaccharide (PNAG) mediated biofilms 58 . Deletion of ica genes responsible of PNAG synthesis, abolish biofilm formation in this strain. As Bap positive strains we used: S. aureus Newman_Bap 59 ; S. aureus C104 60 ; S. aureus V858 61 ; S. saprophyticus B20080011225, S. hyicus 12 and S. simiae CCM7213 17 . Staphylococcal strains were cultured in trypticase soy broth supplemented with glucose (0.25%, w/v) (TSB-glu). Table 1 were obtained from Sigma-Aldrich (purity ≥ 98%; St. Louis, USA) and Quimigen. The stock and work solutions of polyphenols were prepared in a mixture of dimethyl sulfoxide (DMSO). The DMSO that remained after dilution of polyphenol work solutions into culture broth, even at the highest tested concentration (2%, v/v) caused no inhibition of bacterial growth (Supplementary Fig. S3 ).

The MIC values of the polyphenols against S. aureus V329 were determined using the twofold serial microdilution method 62 . The tested compounds were added to a 96-well plate containing sterile TSB-glu medium reaching final concentrations of 5-5000 μg/ml. Bacterial inoculum in the medium without the tested compound served as a positive control, whereas the tested compounds in medium without bacteria served as negative control. Following a 24 h incubation, the bacterial growth was evaluated by measuring the turbidity in each well through spectrophotometric analysis (600 nm). The lowest concentration that did not produce detectable absorbance values until the end of incubation was considered as the MIC. All tests were repeated three times to verify the reproducibility of results. Subsequently sub-MICs values of 1/50x MIC, 1/100x MIC and 1/500x MIC were determined for their capacity to inhibit biofilm formation.

Overnight cultures with OD 600 = 5 (~ 7.5 × 10 9 CFU/ml) were diluted 1:40 in TSB-glu medium with sub-MIC dosages of the polyphenols. To exclude a DMSO effect on biofilm formation, overnight culture was diluted in TSB-glu medium with 2% DMSO. Bacteria culture in TSB-glu media was used as positive control. 200 μl of this cell suspension were inoculated in 96-wells polystyrene microtiter plates. After 18 h of incubation at 37 °C, wells were washed with sterile phosphate-buffered saline (PBS) and stained with 0.1% crystal violet. The optical density at 595 nm of the solubilized colorant was determined using a microplate reader (Multiskan EX; Lab-Systems). Each assay was performed in triplicate. Statistical significance differences were determined with one-way ANOVA followed by Dunn's multiple comparison test: *P < 0.05, **P < 0.01, ***P < 0.001.

Real-time biofilm growth analysis. Continuous real-time biofilm monitoring was performed using xCELLigence RTCA (Real-Time Cell Analysis) equipment (Agilent). This assay is based on the ability of bacteria to impede electric current when they attach and grow on the gold electrodes placed at the bottom of 96-well microtiter plates. Bacterial biofilms grown in microtiter plates with electrodes at the bottom of wells impedes the flow of electrical current. The impedance is expressed as Cell Index (CI) values, which correlate with the total biofilm mass. The experiments were performed as described previously 63, 64 . Briefly, 100 µl of each polyphenol (Table 1 ) diluted in TSB-glu was used as background for impedance measurements (reaching final concentrations of 10 µg/ml for QC, BC and MC and 5 µg/ml for SC, respectively). Further, 100 µl of S. aureus V329 and 15981 bacterial suspensions (OD 600 = 0.175) were added into the corresponding wells of a 96-well plate, reaching an initial optical density of 0.0875 (10 7 -10 8 cells, depending on the strain). Impedance data were registered at 10-min intervals for 50 h at 37 °C. Three replicates of each polyphenol and their respective controls were included in each experiment, which was repeated three times. In order to study statistical differences in biofilm CI values, regression analysis was assessed by a linear model between 15 and 25 h of biofilm growth, using the lm library in the R Statistical Package version 1.0.7.1 (Calgano, 2013) (accessed in November, 2019).

Overnight cultures were diluted 1:100 in media supplemented with MBIC of polyphenols (Table 1) . Bacteria were grown in microtiter plate under static conditions (biofilm formation conditions) until exponential (OD 600nm = 0.8) and stationary phase (OD 600nm = 5). For surface protein extracts, cells were resuspended in 100 μl of PBS containing 26% w/v raffinose (Sigma) and 3 μl of 1 mg/ml lysostaphin and incubated 2 h at 37 °C. For total protein extracts, cells were resuspended in 1 ml of PBS and lysed using FastPrep-24 instrument (MP Biomedicals). Supernatants were quantified using Bio-Rad protein assay kit. 15 μg and 1 μg of proteins were load on acrylamide gels (7.5% and 12% separation gels; 4% stacking gels) and were stained with 0.25% Coomassie brilliant blue R250 as loading controls. For native gels, surface proteins were separated in Criterion 3-8% XT Tris-acetate gels and Tris/glycine running buffer (BioRad). Bap protein was detected using rabbit polyclonal Anti-BapB diluted 1:5000. Peroxidase-conjugated goat anti-rabbit immunoglobulin G diluted 1:5000 (Thermo) was used as a secondary antibody. For detection of GFP, mouse www.nature.com/scientificreports/ monoclonal anti-GFP diluted 1:5000 (Clontech) and peroxidase-conjugated goat anti-mouse immunoglobulin G diluted 1:2500 (Pierce) were used as primary and secondary antibodies, respectively. Full-length gels and blots are included as Supplementary Fig. S4 . (Table 1) . Before measuring thioflavin-T (Th-T) was added at the final concentration of 25 µM. Fluorescence emission spectra were recorded in the 460-600 nm range with an excitation wavelength of 445 nm using a 5 nm slit width for excitation and emission at 25 °C in the multi-mode reader Synergy H1 Hybrid Multi-Mode Reader.

Turbidity test. Turbidity test was used to discriminate false positives identified at the Th-T assay. For this purpose, rBap_B at 0.1 mg/ml was incubated in phosphate-citrate buffer pH 4.4 in the presence of polyphenols: QC 10 μg/ml, MC 10 μg/ml and SC 5 μg/ml. Mixture was incubated in a 96-well plate at 37 °C for 200 min and the absorbance was measured every 10 min at 360 nm. Every polyphenol was tested in triplicate. Recombinant protein without polyphenols was used as a positive control.

Murine model of catheter-associated biofilm formation. Bacteria grown overnight on TSA plates were resuspended in PBS to an OD 0.2 (10 8 CFU/ml). Groups of five-weeks old ICR female mice (n = 6) (Envigo) were anesthetized with isoflurane. Two 19 mm intravenous catheters (24G; B. Braun) were implanted into the subcutaneous interscapular of each mouse and inoculated with 100 µl of S. aureus V329. Polyphenols were administered subcutaneously at the interscapular space during 10 days at non-toxic concentrations of QC 100 mg/kg, MC 20 mg/kg and SC 17.5 mg/kg [65] [66] [67] [68] . After 10 days, animals were anesthetized by isoflurane inhalation followed by euthanatized by cervical dislocation. Catheters were removed and placed in a sterile microcentrifuge tube containing PBS and vortexed at high speed for 3 min. 25 µl of serial dilution bacteria were plated on TSA and incubated overnight at 37 °C for colony formation units (CFUs) count. Sample size calculation has been carried out using the IVS program. No criteria were established for excluding animals. Confounders were not controlled. Statistical significance differences were determined with one-way ANOVA followed by Dunn's multiple comparison test: **P < 0.01, ***P < 0.001.

All animal studies were reviewed and approved by the Comité de Ética para la Experimentación Animal (CEEA) of the Universidad de Navarra (approved protocol 114-17). Work was carried out at CIMA (ES312010000132) under the principles and guidelines described in European Directive 2010/63/EU for the protection of animals used for experimental purposes.

Scientific Reports | (2020) 10:18968 | https://doi.org/10.1038/s41598-020-75929-2 www.nature.com/scientificreports/

Colonization of medical devices by staphylococci

Antibiotics versus biofilm: an emerging battleground in microbial communities

Rapid microevolution of biofilm cells in response to antibiotics

Resistance of nosocomial strains to antibacterial drugs and its link to biofilm formation

A self-produced trigger for biofilm disassembly that targets exopolysaccharide

Current and recent advanced strategies for combating biofilms

Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action

Staphylococcus aureus biofilms: recent developments in biofilm dispersal

Biofilm matrixome: extracellular components in structured microbial communities

Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects

Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus

Role of surface protein SasG in biofilm formation by Staphylococcus aureus

Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms

Amyloid structures as biofilm matrix scaffolds

The role of functional amyloids in bacterial virulence

Bap: a new type of functional amyloid

Staphylococcal Bap proteins build amyloid scaffold biofilm matrices in response to environmental signals

Bap, a Staphylococcus aureus surface protein involved in biofilm formation

Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer

The biofilm-associated surface protein Esp of Enterococcus faecalis forms amyloid-like fibers

Amyloid fiber formation by synthetic peptides derived from the sequence of the protein CsgA of Escherichia coli

Polyphenols: modulators of platelet function and platelet microparticle generation?

A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk

Recent advances on the anti-Inflammatory and antioxidant properties of red grape polyphenols: in vitro and in vivo Studies

A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health

Natural product-based amyloid inhibitors

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases

Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-a review

Antibacterial properties of polyphenols: characterization and QSAR (quantitative structure-activity relationship) models

Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding

Anti-H1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

Antibiofilm activity of plant polyphenols

Effects of various flavonoids on the α-synuclein fibrillation process

A bacterial export system for generating extracellular amyloid aggregates

Benzbromarone, quercetin, and folic acid inhibit amylin aggregation

Structural characteristics of (−)-epigallocatechin-3-gallate inhibiting amyloid Aβ42 aggregation and remodeling amyloid fibers

EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of α-synuclein, and protects PC12 cells against α-synuclein-induced toxicity

Epigallocatechin Gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson's disease

Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG

Zinc boosts EGCG's hIAPP amyloid inhibition both in solution and membrane

Inhibitory mechanism of epigallocatechin gallate on fibrillation and aggregation of amidated human islet amyloid polypeptide

Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models

The green tea polyphenol (−)-Epigallocatechin Gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios

A synergistic small-molecule combination directly eradicates diverse prion strain structures

Plant polyphenols inhibit functional amyloid and biofilm formation in Pseudomonas strains by directing monomers to off-pathway oligomers

Functional amyloids in Streptococcus mutans, their use as targets of biofilm inhibition and initial characterization of SMU_63c

Inhibitory effects of Myricetin derivatives on curli-dependent biofilm formation in Escherichia coli

Targeting bacterial biofilms by the Green Tea polyphenol EGCG

Dissecting the contribution of Staphylococcus aureus α-phenol-soluble modulins to biofilm amyloid structure

Epigallocatechin Gallate remodels overexpressed functional amyloids in Pseudomonas aeruginosa and increases biofilm susceptibility to antibiotic treatment

A possible role for π-stacking in the self-assembly of amyloid fibrils

Microbial amyloids: functions and interactions within the host

Bap, a biofilm matrix protein of Staphylococcus aureus prevents cellular internalization through binding to GP96 host receptor

Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37

SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus

Calcium inhibits bap-dependent multicellular behavior in Staphylococcus aureus

Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence

SarA positively controls Bap-dependent biofilm formation in Staphylococcus aureus

Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution

Effect of antibiotics on biofilm inhibition and induction measured by real-time cell analysis

Effect of Dalbavancin on staphylococcal biofilms when administered alone or in combination with biofilm-detaching compounds

Quercetin inhibits renal cyst growth in vitroand viaparenteral injection in a polycystic kidney disease mouse model

Effect of Gallic acid and Myricetin on ovarian cancer models: a possible alternative antitumoral treatment

Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9

Effect of Scutellarin inhibits collagen-induced arthritis through TLR4/NF-κB-mediated inflammation

This research was supported by Grants RTI2018-096011-B-I00 from Ministry of Science and Innovation and PI011 KILL-BACT from the Government of Navarra.

The authors declare no competing interests.

Supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-75929 -2.Correspondence and requests for materials should be addressed to J.V.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.